These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1856803

  • 1. Methotrexate in rheumatoid arthritis: effects on disease activity in a multicenter prospective study.
    Weinblatt ME, Kaplan H, Germain BF, Merriman RC, Solomon SD, Wall B, Anderson L, Block S, Small R, Wolfe F.
    J Rheumatol; 1991 Mar; 18(3):334-8. PubMed ID: 1856803
    [Abstract] [Full Text] [Related]

  • 2. Longterm prospective study of methotrexate in rheumatoid arthritis: conclusion after 132 months of therapy.
    Weinblatt ME, Maier AL, Fraser PA, Coblyn JS.
    J Rheumatol; 1998 Feb; 25(2):238-42. PubMed ID: 9489813
    [Abstract] [Full Text] [Related]

  • 3. Treatment of rheumatoid arthritis with methotrexate: a prospective open longterm study of 191 cases.
    Sany J, Anaya JM, Lussiez V, Couret M, Combe B, Daures JP.
    J Rheumatol; 1991 Sep; 18(9):1323-7. PubMed ID: 1757932
    [Abstract] [Full Text] [Related]

  • 4. Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six-month, open-label study.
    Kremer JM, Habros JS, Kolba KS, Kaine JL, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisemandle W, Mekki QA, Tacrolimus-Methotrexate Rheumatoid Arthritis Study Group.
    Arthritis Rheum; 2003 Oct; 48(10):2763-8. PubMed ID: 14558080
    [Abstract] [Full Text] [Related]

  • 5. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R, Schleusser B, Herborn G, Karger T.
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [Abstract] [Full Text] [Related]

  • 6. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM, Sandhu S, Lochhead A, Hurst NP, McRorie E, Dhillon V.
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [Abstract] [Full Text] [Related]

  • 7. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V.
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [Abstract] [Full Text] [Related]

  • 8. Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy.
    Stamp LK, O'Donnell JL, Chapman PT, Zhang M, James J, Frampton C, Barclay ML.
    Arthritis Rheum; 2010 Feb; 62(2):359-68. PubMed ID: 20112376
    [Abstract] [Full Text] [Related]

  • 9. [Low dose methotrexate therapy in rheumatoid arthritis].
    Shinozawa T, Akama H, Matsushita Y, Tanaka H, Yamada H, Suzuki Y, Ichikawa Y, Homma M.
    Ryumachi; 1990 Jun; 30(3):172-80. PubMed ID: 2244252
    [Abstract] [Full Text] [Related]

  • 10. Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study.
    Weinblatt ME, Kaplan H, Germain BF, Block S, Solomon SD, Merriman RC, Wolfe F, Wall B, Anderson L, Gall E.
    Arthritis Rheum; 1994 Oct; 37(10):1492-8. PubMed ID: 7945475
    [Abstract] [Full Text] [Related]

  • 11. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.
    Cohen S, Hurd E, Cush J, Schiff M, Weinblatt ME, Moreland LW, Kremer J, Bear MB, Rich WJ, McCabe D.
    Arthritis Rheum; 2002 Mar; 46(3):614-24. PubMed ID: 11920396
    [Abstract] [Full Text] [Related]

  • 12. The efficacy and toxicity of a constant low dose of methotrexate as a treatment for intractable rheumatoid arthritis: an open prospective study.
    Mielants H, Veys EM, Van der Straeten C, Ackerman C, Goemaere S.
    J Rheumatol; 1991 Jul; 18(7):978-83. PubMed ID: 1920332
    [Abstract] [Full Text] [Related]

  • 13. Methotrexate: clinical and immunological effects in refractory rheumatoid arthritis.
    Singh Y, Sharma M, Singh RR, Kumar A, Malaviya R, Malaviya AN.
    J Assoc Physicians India; 1992 Oct; 40(10):658-61. PubMed ID: 1307351
    [Abstract] [Full Text] [Related]

  • 14. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.
    Luis M, Pacheco-Tena C, Cazarín-Barrientos J, Lino-Pérez L, Goycochea MV, Vazquez-Mellado J, Burgos-Vargas R.
    Arthritis Rheum; 1999 Oct; 42(10):2160-5. PubMed ID: 10524688
    [Abstract] [Full Text] [Related]

  • 15. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
    Durez P, Malghem J, Nzeusseu Toukap A, Depresseux G, Lauwerys BR, Westhovens R, Luyten FP, Corluy L, Houssiau FA, Verschueren P.
    Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
    [Abstract] [Full Text] [Related]

  • 16. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.
    Khanna D, Park GS, Paulus HE, Simpson KM, Elashoff D, Cohen SB, Emery P, Dorrier C, Furst DE.
    Arthritis Rheum; 2005 Oct; 52(10):3030-8. PubMed ID: 16200612
    [Abstract] [Full Text] [Related]

  • 17. Can collagen type II sustain a methotrexate-induced therapeutic effect in patients with long-standing rheumatoid arthritis? A double-blind, randomized trial.
    Häuselmann HJ, Caravatti M, Seifert B, Wang K, Bruckner P, Stucki G, Michel BA.
    Br J Rheumatol; 1998 Oct; 37(10):1110-7. PubMed ID: 9825751
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study.
    Furst DE, Saag K, Fleischmann MR, Sherrer Y, Block JA, Schnitzer T, Rutstein J, Baldassare A, Kaine J, Calabrese L, Dietz F, Sack M, Senter RG, Wiesenhutter C, Schiff M, Stein CM, Satoi Y, Matsumoto A, Caldwell J, Harris RE, Moreland LW, Hurd E, Yocum D, Stamler DA.
    Arthritis Rheum; 2002 Aug; 46(8):2020-8. PubMed ID: 12209503
    [Abstract] [Full Text] [Related]

  • 19. Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis.
    Shergy WJ, Isern RA, Cooley DA, Harshbarger JL, Huffstutter JE, Hughes GM, Spencer-Smith EA, Goldman AL, Roth SH, Toder JS, Warner D, Quinn A, Keenan GF, Schaible TF, PROMPT Study Group. Profiling Remicade Onset with MTX in a Prospective Trial.
    J Rheumatol; 2002 Apr; 29(4):667-77. PubMed ID: 11950005
    [Abstract] [Full Text] [Related]

  • 20. Low dose methotrexate in rheumatoid arthritis.
    Steinsson K, Weinstein A, Korn J, Abeles M.
    J Rheumatol; 1982 Apr; 9(6):860-6. PubMed ID: 7161777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.